Nu Skin Enterprises (NYSE: NUS) reported Q1 EPS of $0.37, $0.06 better than the analyst estimate of $0.31. Revenue for the quarter came in at $481.5 million versus the consensus estimate of $476.05 million.

GUIDANCE:

Nu Skin Enterprises sees FY2023 EPS of $2.41-$2.81, versus the consensus of $2.55. Nu Skin Enterprises sees FY2023 revenue of $2.03-2.18 million, versus the consensus of $2.09 million.

Nu Skin Enterprises sees Q2 2023 EPS of $0.45-$0.55, versus the consensus of $0.61. Nu Skin Enterprises sees Q2 2023 revenue of $485-525 million, versus the consensus of $527 million.

For earnings history and earnings-related data on Nu Skin Enterprises (NUS) click here.